Publications by authors named "Ron L Zimmern"

Claim this Profile
C
Conceptual issues for screening in the genomic era - time for an update?
Caroline F Wright, Ron L Zimmern

Epidemiol Biostat Public Health· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A collaboratively-derived science-policy research agenda.
William J Sutherland, Laura Bellingan, Jim R Bellingham, Jason J Blackstock, Robert M Bloomfield, Ron L Zimmern

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulating direct-to-consumer genetic tests: what is all the fuss about?
Caroline F Wright, Alison Hall, Ron L Zimmern

Genet Med· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A reply to community genetics: 1998-2009... and beyond.
Ron L Zimmern

J Community Genet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: A reply to community genetics: 1998-2009... and beyond.
Ron L Zimmern

J Community Genet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Realizing the potential of genomics: translation is not translational research.
Ron L Zimmern, Philippa C Brice

Genet Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic medicine: the future is now. Lessons for Hong Kong from the House of Lords Report on Genomic Medicine.
Ron L Zimmern

Hong Kong Med J· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic tests for common diseases: new insights, old concerns.
David Melzer, Stuart Hogarth, Katherine Liddell, Tom Ling, Simon Sanderson, Ron L Zimmern

BMJ· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association.
Julian P T Higgins, Julian Little, John P A Ioannidis, Molly S Bray, Teri A Manolio, Ron L Zimmern

Am J Epidemiol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evaluation of genetic tests.
Ron L Zimmern, Mark Kroese

J Public Health (Oxf)· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network.
Mark Kroese, Ron L Zimmern, Peter Farndon, Fiona Stewart, Joanne Whittaker

Eur J Hum Genet· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 status in breast cancer--an example of pharmacogenetic testing.
Mark Kroese, Ron L Zimmern, Sarah E Pinder

J R Soc Med· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic tests and their evaluation: can we answer the key questions?
Mark Kroese, Ron L Zimmern, Simon Sanderson

Genet Med· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring the appropriate use of genetic tests.
Wylie Burke, Ron L Zimmern

Nat Rev Genet· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
Melissa A Austin, Carolyn M Hutter, Ron L Zimmern, Steve E Humphries

Am J Epidemiol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
Melissa A Austin, Carolyn M Hutter, Ron L Zimmern, Steve E Humphries

Am J Epidemiol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory options for pharmacogenetics.
David Melzer, Ron L Zimmern, Don E Detmer, Tom Ling

Pharmacogenomics· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia.
Melissa A Austin, Ron L Zimmern, Steve E Humphries

Genet Med· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic susceptibility to breast cancer and implications for prevention.
Paul D P Pharoah, Antonis Antoniou, Martin Bobrow, Ron L Zimmern, Douglas F Easton

Nat Genet· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis